Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3427PDF: 2014HTML: 7570 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1446HTML: 630PDF: 866 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3699PDF: 1140HTML: 23371 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2210PDF: 738HTML: 327 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1268PDF: 626HTML: 269 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4190PDF: 1029HTML: 19208 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1471PDF: 911HTML: 1919 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8191PDF: 4373HTML: 7543 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1823PDF: 900HTML: 449Fig1: 253Fig.2: 268Fig. 3: 207Fig. 5: 215Fig. 4: 243 -
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2406PDF: 1205HTML: 985 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3451PDF: 1506HTML: 4077 -
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
2105PDF: 918HTML: 478 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2269PDF: 1460HTML: 940 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2121PDF: 873HTML: 354 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4633PDF: 1973HTML: 18065 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
994PDF: 587Html: 275Suppl. Files: 187 -
-
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1154PDF: 816Html: 178 -
Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV SARS-CoV-2 and HIV
987PDF: 812HTML: 457 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4013PDF: 1151HTML: 466 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1471PDF: 512HTML: 190 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4156PDF: 1277HTML: 2112Table 1: 212 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2679PDF: 1657HTML: 2441Table1: 206 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
643PDF: 319Suppl. Files: 81Html: 70







